Stents Vs. Balloons Question For Peripheral Artery Disease Gets Attention At Veith

The presence of the first drug-eluting stent on the U.S. market to treat peripheral artery disease is certainly not the end of the discussion for how peripheral artery patients will be treated, clinicians made clear at the influential Veith Symposium this month.

More from Archive

More from Medtech Insight